User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 6 results.
    • Journal article
    Preliminary tolerance analysis of adjuvant chemotherapy in older patients after resection of stage III colon cancer from the PRODIGE 34-FFCD randomized trial
    Aparicio, Thomas Bouché, Olivier Etienne, Pierre-Luc Barbier, Emilie Mineur, Laurent Desgrippes, Romain Guérin-Meyer, Véronique Hocine, Fayçal Martin, Jean Le Brun-Ly, Valérie Cretin, Jacques Desramé, Jérôme Rinaldi, Yves Cany, Laurent Falandry, Claire Lefevre, Leila Bengrine Marous, Miguelle Terrebonne, Eric Mosser, Laurent Turpin, Justine Turpin, Anthony Bauguion, Lucille Reichling, Cynthia Van den Eynde, Marc[UCL] Carola, Elisabeth Hiret, Sandrine (2023) Digestive and liver disease — Vol. 55, no. 4, p. 541-548 (2023)
    • Journal article
    Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: post hoc analysis of the CORRECT phase III trial (RadioCORRECT study).
    Ricotta, Riccardo Verrioli, Antonella Ghezzi, Silvia Porcu, Luca Grothey, A Falcone, Alfredo Van Cutsem, Eric Argilés, Guillem Adenis, Antoine Ychou, Marc Barone, Carlo Bouché, Olivier Peeters, Marc Humblet, Yves[UCL] Mineur, Laurent Sobrero, Alberto F Hubbard, Joleen M Cremolini, Chiara Prenen, Hans Tabernero, Josep Jarraya, Hajer Mazard, Thibault Deguelte-Lardiere, Sophie Papadimitriou, Konstantinos Van den Eynde, Marc[UCL] Pastorino, Alessandro Redaelli, Daniela Bencardino, Katia Funaioli, Chiara Amatu, Alessio Carlo-Stella, Giulia Torri, Valter Sartore-Bianchi, Andrea Vanzulli, Angelo Siena, Salvatore (2017) ESMO Open — Vol. 1, no. 6, p. e000111 [1-10] (2017)
    • Journal article
    Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: A retrospective, exploratory analysis of the CORRECT trial
    Tabernero, Josep Lenz, Heinz-Josef Siena, Salvatore Sobrero, Alberto Falcone, Alfredo Ychou, Marc Humblet, Yves[UCL] Bouché, Olivier Mineur, Laurent Barone, Carlo Adenis, Antoine Yoshino, Takayuki Goldberg, Richard M. Sargent, Daniel J. Wagner, Andrea Laurent, Dirk Teufel, Michael Jeffers, Michael Grothey, Axel Van Cutsem, Eric (2015) The Lancet Oncology — Vol. 16, no. 8, p. 937-948 (2015)
    • Journal article
    Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial.
    Hammel, Pascal Huguet, Florence van Laethem, Jean-Luc Goldstein, David Glimelius, Bengt Artru, Pascal Borbath, Ivan[UCL] Bouché, Olivier Shannon, Jenny André, Thierry Mineur, Laurent Chibaudel, Benoist Bonnetain, Franck Louvet, Christophe LAP07 Trial Group (2016) JAMA : the journal of the American Medical Association — Vol. 315, no. 17, p. 1844-1853 (2016)
    • Journal article
    Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial
    Grothey, Axel Van Cutsem, Eric Sobrero, Alberto Siena, Salvatore Falcone, Alfredo Ychou, Marc Humblet, Yves[UCL] Bouché, Olivier Mineur, Laurent Barone, Carlo Adenis, Antoine Tabernero, Josep Yoshino, Takayuki Lenz, Heinz-Josef Goldberg, Richard M Sargent, Daniel J Cihon, Frank Cupit, Lisa Wagner, Andrea Laurent, Dirk CORRECT Study Group (2013) The Lancet — Vol. 381, no.9863, p. 303-12 (2013)
    • Journal article
    A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapy
    Saridaki, Zenia Weidhaas, Joanne B. Lenz, Heinz-Josef Laurent-Puig, Pierre Jacobs, Bart De Schutter, Jef De Roock, Wendy Salzman, David W. Zhang, Wu Yang, Dongyun Pilati, Camilla Bouché, Olivier Piessevaux, Hubert[UCL] Tejpar, Sabine (2014) Clinical Cancer Research — Vol. 20, no. 17, p. 4499-4510 (2014)